Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UNP vs MRNA✓SelectedUSD · MRNAUNP vs MRNA performance historyLatest closeAs of-2.20%11/17
Stock and ETF performance explorer

UNP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+138.8%
MRNA return
+840.0%
Excess return
-701.2%
Maximum drawdown
-38.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.2%-3.9%+1.7%-2.1%
7D-1.2%-17.6%+16.4%-0.9%
30D+2.8%-5.1%+7.9%+2.8%
3M-0.5%+220.8%-221.3%-3.7%
6M+10.9%+321.7%-310.8%+6.3%
YTD+30.4%+601.3%-570.9%+22.9%
1Y+37.2%+735.2%-698.0%+28.7%
3Y+44.8%+170.5%-125.8%+37.7%
5Y+38.7%-14.6%+53.3%+32.0%
All+138.8%+840.0%-701.2%+128.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling